Richard Sanford Finkel MD

Child Neurology•Memphis, TN

Neuromuscular Medicine

Director, Center for Experimental Neurotherapeutics at St. Jude Children's Research Hospital

Join to View Full Profile

St. Jude Children's Research Hospital262 Danny Thomas PlaceMemphis, TN 38105

Education & Training

Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 1980 - 1983
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1978 - 1980
Washington University in St. Louis School of MedicineClass of 1978

Certifications & Licensure

FL State Medical License 2012 - 2026
IL State Medical License 2023 - 2026
KY State Medical License 2023 - 2026
TN State Medical License 2020 - 2026
AL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
PA State Medical License 1999 - 2014
CO State Medical License 1983 - 2001
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
Join now to see all

Clinical Trials

Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy Start of enrollment: 2005 Dec 01
Completed
Phase 2
A Pilot Study of Biomarkers for Spinal Muscular Atrophy Start of enrollment: 2008 Oct 01
Completed
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others Start of enrollment: 2010 Apr 01
Recruiting
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2 Start of enrollment: 2010 May 01
Recruiting
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT Start of enrollment: 2010 Apr 01
Recruiting
Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
Completed
Phase 3
A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
Terminated
Phase 3
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy Start of enrollment: 2014 Apr 17
Completed
Phase 2
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
Terminated
Phase 3
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
COMPLETED
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy Start of enrollment: 2017 Jun 06
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

The Spastic Paraplegia-Centers of Excellence Research Network (SP-CERN): Clinical Trial Readiness for Hereditary Spastic Paraplegia.
Luca Schierbaum, Vicente Quiroz, Kathryn Yang, Joshua Rong, Nicole Battaglia
Neurology. Genetics. 2025-04-01
Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy.
Richard S Finkel, Samuel H Hughes, JulieAnn Parker, Matthew Civitello, Alfonso Lavado
The New England Journal of Medicine. 2025-03-13
2 citations
TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestations.
Gage P Kosmanopoulos, Jack K Donohue, Maya Hoke, Simone Thomas, Margo A Peyton
Brain. 2025-01-07

Press Mentions

This Rare Genetic Disorder Was Just Treated in the Womb for the First Time EverFebruary 20th, 2025
Alcyone Wins Breakthrough Device Status for Delivery DeviceMarch 11th, 2019
Drug to Treat 'Floppy Baby Syndrome' Takes Home Multi-Million Dollar Prize at the 'Oscars for Science'October 17th, 2018
Join now to see all